VFY — Vitrafy Life Sciences Share News
0.000.00%
Last trade - 00:00- AU$215.61m
- AU$189.81m
- AU$0.17m
Australia's Vitrafy Life Sciences heads for best day in 2 months on Versiti deal
Australia's Vitrafy Life Sciences gains on entering US market
Brief: Vitrafy Life Sciences Enters U.S. Cell & Gene Therapy Market With Charter Medical Agreement
Brief: Vitrafy Life Sciences Posts FY Operating Loss Of A$14.6 Million
Brief: Vitrafy Life Sciences Enters A Partnership With Hoxworth Blood Center
Australia's Vitrafy Life Sciences slumps on discounted placement
Brief: Vitrafy Life Sciences Receives Firm Commitments For A$30 Million Placement
Brief: Vitrafy Life Sciences Seeks Trading Halt
Brief: Vitrafy Life Sciences Enters Partnership With Vitalant Innovation Center
Brief: Vitrafy Life Sciences Posts HY Loss After Tax A$7.1 Million
Brief: Vitrafy Life Sciences Enters Strategic Commercial Agreement With IMV Technologies
Australia's Vitrafy Life Sciences rises on partnership with IMV Technologies
Brief: Vitrafy Life Sciences Says Chair Sonia Petering To Retire At 2025 AGM
Australia's Vitrafy Life Sciences flat; Bell Potter raises PT on cash flows hopes
Brief: Vitrafy Life Sciences Announces Leadership Transition
Australia's Vitrafy Life Sciences hits record low on interim loss
Brief: Vitrafy Life Sciences Posts HY Loss Attributable A$25.7 Million